Journal Article Summary
The article investigates the effectiveness and safety of two types of medications—phosphodiesterase 5 inhibitors (PDE5-Is) and alpha-1 blockers (ABs)—in treating lower ureteric stones and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). This topic is significant because both conditions are prevalent among older men and can severely impact their quality of life. Understanding the best treatment options can help improve patient outcomes and reduce healthcare costs associated with these common urological issues.
The researchers conducted a meta-analysis of 17 randomized controlled trials published up to November 2016, involving a total of 1,913 patients. They found that combination therapy using both PDE5-Is and ABs was more effective than using either medication alone for treating lower ureteric stones and LUTS. Specifically, the combination therapy led to higher stone expulsion rates and shorter expulsion times, while ABs were more effective in reducing symptoms related to LUTS. Both treatment approaches were deemed safe, with a lower incidence of adverse effects reported for PDE5-Is compared to ABs.
However, the study has limitations, including variability in the quality and duration of the included trials, which may affect the reliability of the results. Patients should be aware that while both treatment options are generally safe, individual responses can vary, and some may experience side effects. It is advisable for readers to discuss these findings and their treatment options with a healthcare professional to determine the most appropriate approach for their specific situation.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sun Xifeng, Guan Wei, Liu Haoran, Tang Kun, Yan Libin, Zhang Yangjun, Zeng Jin, Chen Zhiqiang, et al.. Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs. BMC Urology 2018. DOI: 10.1186/s12894-018-0345-4. PMID: 29724204. PMCID: PMC5934901.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets — Generic for Cialis — Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
